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ABSTRACT 
Introduction: Women who partake in Ramadan during pregnancy have lower placental 
weights. Intermittent fasting (IF) impacts upon asynchronous dietary cues and the entrained 
sleep cycle. The effects of IF on placental development and function have not been studied. 
Amino acid and calcium transport are key markers of a placentas nutrient transporting 
capabilities and are measured in pathological pregnancies to evaluate placental function. 
 
Hypothesis: IF alters regulation of nutrient transporters in the placenta which may impact 
fetal wellbeing. These transporters may be under direct circadian control.  
 
Methods: Rats were used to model either control or IF diet regimes during pregnancy. At 
term, fetal and placental weights were recorded and placental tissues homogenised. BeWo, 
a trophoblast-derived cell line, were cultured in different glucose concentrations to mimic 
asynchronous dietary cues. For both models protein content of key amino acid and calcium 
nutrient transporters (SNAT2, TRPV6, PMCA and Calbindin-D9K) and circadian machinery 
proteins (CLOCK and BMAL1) were quantified by western blotting. Analysis determined 
localisation and expression in response to dietary cues.  
 
Results: Rat placental weight was reduced and fetal weight increased in IF versus control 
diets. Placental protein expression of TRPV6 and PMCA and SNAT2 was decreased 
whereas CLOCK protein was increased. In BeWo, both CLOCK and BMAL1 were localised 
to the nucleus and cytoplasm. Asynchronous dietary cues manipulate the expression of 
CLOCK and BMAL1 in BeWo. Serum shocking did not stimulate circadian oscillations in 
BeWo, but reduced CLOCK expression. 
 
Discussion: The IF rat model mimicked effects on placental weight seen in humans during 
Ramadan. This coincided with aberrant nutrient transporter expression and circadian 
disruption. Placental reserve capacity may account for discrepancies in placental size and 
fetal weight seen in this model. Both models suggest that circadian machinery exists in 
placental trophoblasts. Transporter activity during circadian disruption should be investigated 
to reveal the effect of IF during pregnancy on placental function and fetal outcome. 
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CHAPTER 1: IMPLICATIONS OF INTERMITTENT FASTING ON 
PLACENTAL FUNCTION: A REVIEW OF THE LITERATURE  
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1.1 INTRODUCTION  
Intermittent fasting (IF) is practiced widely across the globe for a number of reasons 
including religious festivals and supposed health benefits. As the impact of a period of IF has 
been further explored the focus has shifted towards effects it may have on pregnancy 
outcome. An adequate and regular source of nutrients is one key component to maintaining 
fetal growth and health; as such a period of fasting during gestation may have implications 
on fetal development. The placenta is the first organ to form during embryogenesis and 
plays a key role in fetal survival. One important element of placental physiology is its ability 
to efficiently transport nutrients from maternal to fetal circulation. Problems within the 
formation, development and function of the placenta have been frequently linked to poor 
pregnancy outcome with serious detrimental effects on fetal growth and wellbeing. 
Understanding the intricate relationship between placental development and function and 
fetal wellbeing is therefore a rapidly increasing area of research in both a clinical and basic 
science arena. In vivo and in vitro models are utilised to unravel placental physiology so 
nutrient transport is better understood. Both the disruption of the sleeping pattern and the 
change to dietary cues brought about by the intermittent nature of fasting periods may also 
have a role to play in the development of the placenta and fetal outcome via tissue specific 
circadian machinery located within the placenta.  
The main aims of this literature review are three-fold; firstly to discuss intermittent fasting 
and its physiological effects on pregnancy outcome including the ability of asynchronous 
dietary cues and disrupted sleep patterns to disturb normal circadian oscillations. Secondly, 
to discuss the structure and function of key nutrient transporting zones in the placenta during 
healthy pregnancy. Finally this literature review will address the impact of circadian 
machinery and its ability to disrupt normal placental function 
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1.2 INTERMITTENT FASTING 
1.2.1 THE CULTURE OF INTERMITTENT FASTING 
Dietary restriction has been shown to have several health benefits; these include increased 
life span, delayed or prevented age related diseases, and improved functional and metabolic 
cardio-vascular health in rodents (Mager et al. 2006). Although most of these affects have 
been correlated with decreased caloric intake, another form of dietary restriction termed 
intermittent fasting (IF), in which not the calorie intake is reduced but the frequency by which 
calories are consumed, has shown similar results. Furthermore IF has been shown to impart 
beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to 
injury from calorie intake (Anson et al. 2003).The bodybuilding community advocates the IF 
principle after a range of studies reported benefits in fat metabolism, weight loss, cardio 
protection and insulin resistance (Smeets and Westerterp-Plantenga 2008;Klempel et al. 
2010;Higashida et al. 2013). 
IF is a key area of interest because of its relevance to real world situations; during the holy 
month of Ramadan it is obligatory for all adult Muslim’s to abstain from the consumption of 
food and drink from sun rise until sunset. Seasonal variation can alter the fasting hours of 
Ramadan because the Arabic calendar is dependent on the moon. Although pregnant 
women are exempt from the fasting period, many choose to participate on social grounds. 
Several studies have been conducted looking into the physiological effects this period of 
intermittent fasting has on the healthy non-pregnant body. It is widely reported that body 
weight and body mass index are reduced during the fasting period in both males and 
females (Ziaee et al. 2006;Lamri-Senhadji et al. 2009). Findings have also shown changes in 
blood pressure, lipids, apoproteins, fasting blood sugar, hormones and other biochemical 
parameters (Sarraf-Zadegan et al. 2000) indicating that fasting brings about sweeping 
changes in basic physiology.  
The restriction of food is not the only challenging aspect of the fast. It has previously been 
reported that people practicing Ramadan are in a constant state of dehydration, suffer from 
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headaches and are sleep deprived (Leiper et al. 2003). It is also important to remember that 
Ramadan type fasting also brings about complications other than those associated with 
caloric restriction. The diurnal nature of humans is disrupted by the timing of the Ramadan 
fasts and thus changes typical feeding behaviour. Night time eating leads to a different 
sleep/wake cycle to that which is usually adhered to and also brings about asynchronous 
dietary cues, to which the body must adapt. It is well documented that disruptions to normal 
sleep wake cycles and eating patterns can cause a number of problems including 
desynchronisation of molecular clocks in both peripheral tissues and the central nervous 
system (Haus and Smolensky 2006). 
1.2.2 IMPLICATIONS OF IF IN PREGNANCY 
Although the physiological changes in the normal human body have been studied there is 
not a vast amount of information on the effects of intermittent fasting during pregnancy and 
the implications it may have on fetal health. Although pregnant women are exempt from the 
fasting period many still choose to participate fully on social grounds or participate in a 
limited capacity due to their pregnant state (Joosoph et al. 2004). Several studies have 
focused on physiological changes that occur during pregnancy and Ramadan. These studies 
have reported no differences between breast milk composition, a significant difference in 
fetal breathing movements during the fasting periods and finally, no difference between the 
uterine blood flow between control and fasting counterparts (Bener et al. 2001;Mirghani et al. 
2004;Mirghani et al. 2007). More recently the placenta and pregnancy outcome during 
Ramadan have come under investigation.  
A study looking into the effects of Ramadan fasting on pregnancy has found that babies who 
were exposed to maternal IF in utero during the second or third trimester of pregnancy had 
unaffected birth weight at term, however they had reduced placental weight at birth. This 
suggests that placentas used a reserve capacity to increase efficiency per gram of placental 
tissue and maintain adequate fetal growth despite their decreased size (Alwasel et al. 2010) 
(a phenomenon which has been observed in other environmental stressors of pregnancy 
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such as high altitude or maternal anaemia (Fox 1997)). The authors go on to tentatively 
suggest that the placental changes seen in Ramadan may be associated with fetal 
programming and health implications in the future. It should be noted however that 
monitoring human pregnancy during Ramadan is notoriously difficult. This study was limited 
by location, as the investigators only sampled one city, and by season, because the study 
was conducted over four years during which Ramadan only occurred in three different 
months. The mechanisms behind the changes witnessed during intermittent fasting remains 
unknown. However, it is important that we understand healthy placental physiology to be 
able to begin unravelling the placental reserve capacity and to what extent it can maintain 
fetal nutrition with regards to an altered maternal diet during gestation.  
1.3 THE PLACENTA 
1.3.1 DEVELOPMENT AND STRUCTURE 
The human placenta is haemomonochorial with maternal and fetal blood circulations 
separated by a single syncytial membrane layer to facilitate transport of oxygen and 
nutrients from mother to fetus. Early placental development occurs in a five day 
differentiated blastocyst, in which trophectoderm derived placental cells, known as 
trophoblast cells, are the first fetal cells to form during implantation post blastocyst 
attachment to the endometrium. The trophoblasts cells form a uninucleate, single layer outer 
wall encasing the inner cell mass from which the embryo and umbilical cord derive (figure 
1.3.1).  
As time progresses trophoblastic cells continue to differentiate and form a double layer; the 
inner layer becomes the mononuclear cytotrophoblast layer whilst concurrently the outer 
maternal facing layer becomes the syncytiotrophoblast formed via fusion of cytotrophoblast 
cells to form a monocytoplasmic, multinuclear cell. The cytotrophoblasts act as “stem cells” 
that allow the process of fusion to continue throughout the gestational period for the renewal 
and maintenance of the syncytiotrophoblast layer. 
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During the early phase of placental maturation another sub class of trophoblastic cells 
known to proliferate from the cytotrophoblast cells, are the invasive extravillous trophoblasts 
(EVT). The EVT is responsible the invasion of the maternal endometrium and the 
manipulation of the spiral arteries to increase blood flow towards the fetus through the 
placenta (Forbes and Westwood 2010). Endovascular EVT migrate to the artery lumen and 
begin to degrade smooth muscle, these are soon replaced by trophoblast cells fixed in 
fibrinoid. Their function is to cause enlargement of the spiral arteries to increase maternal 
blood supply for the period of gestation (Kaufmann et al. 2003;van der Heijden et al. 2004), 
effects of which are not entirely reversed postnatally (figure 1.3.2). 
The trophoblast lineage then plays a key role in the development of the villous tree structure. 
Small vacuoles start to form in the syncytiotrophoblastic mass. As the placenta matures, 
these mature to form complex branched “tree like” structures originating from chorionic 
(fetal) side and comprising of the syncytiotrophoblast on top of regenerating cytotrophoblast 
cells and stromal core containing fetal blood vessels (figure 1.3.3) (Benirschke 1973). The 
villous trees branch into the intervillous space from the fetal facing chorionic plate to come 
into direct contact with maternal blood flooding the intervillous space from the remodelled 
spiral arteries (figure 1.3.4). The proximity of maternal and fetal circulatory systems allows 
for the syncytiotrophoblast to become the key nutrient transporting zone in the human 
placenta (Burton 2006).  
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Inner cell mass 
Trophoblasts 
Blastocyst cavity 
Figure 1.3.1:  Five days after fertilisation the early embryo undergoes cell differentiation and structural changes to 
become the blastocyst. The inner cell mass is surrounded by a single cell layer of trophoblasts creating a 
blastocyst cavity. 
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Figure 1.3.2: The early development of trophoblast cells in implantation invasion into the endometrium. A) 
Implantation of blastocyst with outer trophoblast wall onto the endometrium. B) Extra villous trophoblasts (EVT) 
invade into the endometrium in search of maternal blood supply. C) Endovascular trophoblasts (arrows) break 
down smooth muscle lining of maternal spiral arteries causing widening of the artery lumen and increased blood 
flood to the placenta and intervillous space. Adapted from (Parham and Moffett 2013).  
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Figure 1.3.3: The syncytiotrophoblast functions as a protective barrier for the fetus whereas the extravillous 
trophoblasts invade maternal circulation. The villous stroma contains numerous cell types including placental 
macrophages, endothelial cells and fibroblasts. It is located directly beneath the cytotrophoblast layer. Adapted 
from (Forbes and Westwood 2010). 
 
Extravillous Trophoblast 
Cytotrophoblast 
Differentiating 
Cytotrophoblast 
Syncytiotrophoblast 
Microvillous membrane 
Endometrium 
Intervillous Space 
Endometrium 
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Five key stages of villous maturation occur throughout gestation to enable the placenta to 
comply with fetal demands and sustain fetal growth and development. Stem villi form from 
the chorionic plate and provide an anchoring structure for further branching. Following 
branching gives rise to mesenchymal, immature intermediate villi, mature intermediate villi 
and finally terminal villi. This progressive vasculature development is characterised by the 
sub-divisions of branching capillaries becoming finer at each step (Fox 1997). The 
development of the placenta sees an increase in efficiency and this is reflected in the villous 
branching structures. The terminal villi are recognised as the main functional transport sites 
of the placenta. The large surface area of the villous tree bathed in maternal blood, 
multinucleated syncytium and short distances between syncytium and fetal capillaries allow 
for efficient transport of nutrients and oxygen between mother and fetus whilst maintaining 
separate circulations. Aberrations of this stage of development have detrimental effects on 
fetal wellbeing with defects in placental angiogenesis and early placental development being 
linked to early onset intrauterine growth restriction (IUGR) (Kingdom 2000). 
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Figure 1.3.4: Placental villous tree structure. Fetal capillaries are located within the villous structures close to the 
interface between maternal and fetal circulation. The large surface area of the villous tree is bathed in maternal 
blood, multinucleated syncytium and short distances between syncytium and fetal capillaries allow for efficient 
transport of nutrients and oxygen between mother and fetus whilst maintaining separate circulations. Figure 
adapted from (Gallery 2011). 
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1.3.2 THE SYNCYTIOTROPHOBLAST 
The syncytiotrophoblast is comprised of a multinucleated, monocytoplasmic cell, called the 
syncytium which is highly specialised in order to carry out its main functions, which are 
twofold. Firstly, the membrane is adapted to transfer nutrients, ions and waste products 
between maternal and fetal circulations. These adaptations include the presence of a 
microvillous brush border membrane facing the maternal circulation to increase surface area 
combined with the relocation of syncytial nuclei into aggregates to allow fetal capillaries to 
run close to the syncytial membrane to decrease diffusion distance and thus increase 
efficiency (Eaton 1993). 
Secondly the synthesis of steroid and peptide hormones required for fetal development. 
Among these are human chorionic gonadotropin (hCG) and progesterone (Ogren 1994).  
Production of hCG begins early in pregnancy as its initial role is to stop the degradation of 
the corpus luteum. The corpus luteum then goes on to secrete the progesterone necessary 
to prevent early uterine contractions which would otherwise halt pregnancy via menstruation 
(Jameson and Hollenberg 1993).  
Terminal villi, as described in section 1.2.1, are encompassed by the syncytiotrophoblast. 
The maintenance of syncytiotrophoblast is essential; thus there is a regenerative process 
that lasts throughout gestation which occurs via the proliferation of mononuclear 
cytotrophoblasts and the apoptosis of ageing syncytiotrophoblast nuclei.   
 
1.4 PLACENTAL NUTRIENT TRANSPORT 
Materno-fetal transport of nutrients, gases and waste products is not passively facilitated by 
the placenta but an actively controlled and mediated response to fetal demand signals. The 
placenta transports multiple nutrients, such as amino acids and calcium, and thus has 
adapted several systems.   
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1.4.1 SYSTEM A AMINO ACID TRANSPORT 
Amino acid transport remains vital throughout the gestational period to provide both the 
components of proteins and the essential precursors for other non-protein substances. 
Amino acid transporter proteins are localised to both the microvillous membrane (MVM) and 
basal membrane (BM) of the syncytiotrophoblast. They differ in structure, function, 
dependency and specificity (Grillo et al. 2008). System A transporters include SNAT1, 2 and 
4 which are specific for the transport of small zwitterionic, neutral amino acids (Johnson and 
Smith 1988). SNAT 3 and 5, however, are system N transporters the primary function of 
which is glutamine transport. This report will focus on the sodium dependent amino acid 
transport systems which are encoded by the Slc38a gene family which gives rise to three 
highly homologous protein isoforms of system A transporter, SNAT1, 2 and 4. Expression of 
the different isoforms is reported to be tissue specific, apart from SNAT2 which shows 
ubiquitous mammalian expression (Desforges et al. 2006). 
It has been reported that SNAT isoforms 1, 2 and 4 are present in the placenta. More 
recently it has also been reported that SNAT3 is present in the placenta during early 
pregnancy (Novak et al. 2006;Yoshioka et al. 2009). SNAT4 mRNA (expression of the gene 
Slc38a4) is highest in the first trimester of gestation; in contrast it has been shown that 
protein expression is highest at term. This mirrors data suggesting all SNAT isoforms 
increase in expression between days 14 to 20, near the end of gestation, in the rat placenta 
(Novak et al. 2006). These data indicate there is an increased need for amino acids by the 
fetus and placenta in the final trimester. This this would be expected as it has previously 
been reported that fetal growth rates overtake those of the placenta in the final portion of 
pregnancy (Schneider 1996). 
Maternal plasma levels of amino acids decrease by up to 25% below non-pregnant 
measurements as early as the first trimester of pregnancy which is converse to the 186% 
increase in seen in the intervillous space in the placenta (Camelo et al. 2004). Dietary 
changes to system A transport regulation are well documented, in particular changes to the 
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SNAT2 isoform. SNAT2 regulation is reported to be the most adaptable under nutritional 
challenge (Franchi-Gazzola et al. 1999).  Adaptive regulation of system A can be shown in 
mesenchymal cells in the form of a marked increase in System A activity after a period of 
incubation in amino acid free media (Gazzola et al. 1972). Further to this, human fibroblasts 
which underwent a period of incubation in hypertonic conditions displayed an up regulation 
of system A activity which is attributed with restoring cell volume after shrinkage (Dall'Asta et 
al. 1994b). Indicating System A transport into the cell is important for retaining normal 
function after a period of stress. In addition to these studies it has been reported that in 
BeWo a period of amino acid starvation stimulates an increase in α methyl-amino isobutyric 
acid transport after as little as 1 hour post incubation, however this increase in activity was 
not mirrored in an increase in SNAT2 mRNA until 3 hours after incubation began and it took 
a further 3 hours before protein expression to significantly increased (Jones et al. 2006b). 
 
1.4.1.1 System A and pregnancy complications 
IUGR in human pregnancy is associated with a decrease in placental system A transporter 
expression; it has also been shown in animals that this down-regulation precedes IUGR 
(Jansson et al. 2006). Other evidence presented from animal studies reaffirms this 
conclusion. In one study, the system A transport axis was inhibited in the rat placenta by 
using a non metabolisable amino acid analogue and this in turn led to IUGR (Cramer et al. 
2002). A second rat study reported altered function of system A amino acid transport during 
dietary change. A low protein maternal diet resulted in placental system A transport activity 
reduction by E19 of gestation. The same low protein model resulted in IUGR at term and the 
authors were able to conclude that the decrease in amino acid transport was a cause, rather 
than the result, of IUGR (Jansson et al. 2006). 
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1.4.2 PLACENTAL CALCIUM TRANSPORT AND CALCIUM HOMEOSTASIS 
REGULATION 
 
The ionic form of calcium (Ca2+) is found ubiquitously in human tissues and serves many 
purposes; it mediates neurotransmission, enzyme and hormone secretion, apoptosis and 
cell cycle regulation (Clapham 1995). Fetal Ca2+ demand during gestation puts considerable 
strain on the mother’s calcium economy and during the final trimester of pregnancy the fetal 
Ca2+ demand reaches its peak when two-thirds of the total Ca2+ demand is transferred 
across the placenta. Although interactions between Ca2+ homeostasis and Ca2+ transport are 
complex it is known that disruptions to Ca2+ homeostasis throughout the course of gestation 
can lead to an increased risk of developing osteoporosis later in life (Tobias and Cooper 
2004). This is understandable as approximately 80% of the Ca2+ forming the fetal skeleton at 
the end of gestation has been transported across the placenta from the mother.  
In humans the fetus requires an average daily transfer of 200mg of Ca2+, leading to a typical 
accretion of 21g by term (Kovacs et al. 2002). It is of particular interest to neonatologists as 
the precise measurement of mineral transport will aid in the supplementation of Ca2+ to 
support fetal development in cases of premature birth or low bone mass (Abrams 2007). It 
has been estimated that the cytoplasmic concentration of Ca2+ in the syncytiotrophoblast can 
be up to 1000 times higher than free circulating Ca2+  in maternal circulation (Greer 1994). It 
is intriguing that this highly active trophoblast layer of the placenta, which undergoes 
relentless proliferation, differentiation and apoptosis, utilises the Ca2+ ion as an intracellular 
messenger to mediate these cellular processes in a high Ca2+ setting (Berridge et al. 2003). 
Further studies into placental regulation and homeostasis of calcium may increase our 
understanding of placental pathologies that affect healthy fetal development.  
 
1.4.2.1 Calcium Transport and Homeostasis 
Calcium transport by epithelial tissues is widely recognised across mammals to be of similar 
disposition. To begin with, apical Ca2+ entry involves voltage gated epithelial Ca2+ channels. 
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Next, Ca2+ is ferried across the cell cytoplasm via a binding action before being deposited 
out of the cell via active transport on the BM (Bindels 1993). Following the identification of 
the Ca2+ transporting process, more in depth studies have been conducted and the route of 
Ca2+ through the placenta is postulated as follows: 1) diffusion into the trophoblast from 
maternal plasma down an electrochemical gradient through epithelial Ca2+ channels of the 
transient receptor potential (TRP) gene family; 2) transfer across the trophoblast cytoplasm 
bound to the Ca2+ binding protein calbindin-D9K and 3) active extrusion into the fetal 
compartment via the plasma membrane Ca2+-ATPase localised to the fetal facing basal 
plasma membrane (figure 1.3.2). The three proteins characterised above are known as 1) 
Epithelium Ca2+ channel (ECaC); 2) Calbindin-D9K and 3) Ca2+-ATPase (PMCA) (Bond et al. 
2008). Ca2+ transport across the placenta is now considered a dynamic process as the 
placenta is thought to be able to adapt to meet fetal demand signals. Several factors, 
including the calciotropic hormone parathyroid hormone-related protein and the Ca2+ sensing 
receptor (CaSR) on both the maternal and fetal side are partly responsible for the 
maintenance of Ca2+ flux across the placenta. 
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Figure 1.4.2: Ca2+ transport through the syncytiotrophoblast. Showing  diffusion into the trophoblast from maternal 
plasma down an electrochemical gradient through epithelial Ca2+ channels, transfer across the trophoblast 
cytoplasm bound to the calcium binding protein calbindin-D9K  (CaBP9K) and active extrusion into the fetal 
compartment via the plasma membrane Ca2+-ATPase localised to the fetal facing basal plasma membrane. 
Adapted from Slepchenko and Bronner which outlines calcium transport in the gut, the next section goes on to 
outline why this model is relevant to trophoblastic calcium transport also (Slepchenko and Bronner 2001). 
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1.4.2.2 Parathyroid hormone-related protein in calcium homeostasis 
Parathyroid hormone-related protein (PTHrP), which is produced by the placenta (Tobias 
and Cooper 2004), was first identified as the humoral factor responsible for hypercalcemia of 
malignancy. Further investigation led to the identification of PTHrP in a range of fetal and 
adult tissues (Philbrick et al. 1996). PTHrP is a complex prohormone which has been shown 
to undergo post-translational cleavage by the action of prohormone convertases to create a 
family of peptides, each member of which has its own receptor. The availability of the PTHrP 
fetal knockout mouse (NL) have led to further elucidation of the role the protein plays in 
calcium regulation in the placenta. It has been shown that NL fetuses exhibit a significantly 
reduced fetal blood calcium concentration resulting in the suppression of the maternal-fetal 
Ca2+ gradient (Kovacs et al. 1996). The authors suggested that maternal-fetal Ca2+ flux was 
reliant upon fetal PTHrP regulation. Further investigation, however, has shown that the 
abolition of the PTHrP gene does not lead to a decrease total Ca2+ accretion in the fetus but 
merely decreases circulating Ca2+ levels. This indicates that although PTHrP may cause 
disruptions to Ca2+ transport and abolish the maternal-fetal concentration gradient, there is a 
compensatory mechanism that increases Ca2+ deposition in the skeleton of the NL fetus 
(Tucci et al. 1996). The role of PTHrP in maintaining Ca2+ homeostasis during gestation 
remains unclear. More recent work has shown, using in situ placental perfusion, that 
maternal-fetal Ca2+ transport across the placenta is increased despite reduction of Ca2+ in 
fetal circulation (Bond et al. 2008) thus indicating that placental Ca2+ transport is not reliant 
upon the presence of PTHrP.  
 
1.4.2.3 Calcium sensing receptor 
The calcium sensing receptor (CaSR) is expressed in numerous tissues including the 
parathyroid gland, bone, intestine, kidney, brain, skin, lung and heart (Aida et al. 1995;Bikle 
et al. 1996;Garrett et al. 1995;House et al. 1997;Malaisse et al. 1999;Riccardi et al. 
1996;Ruat et al. 1995;Rutten et al. 1999). It is a G-coupled protein receptor with seven 
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transmembrane spanning regions which responds to extracellular Ca2+ concentration (Brown 
et al. 1995). Mutations in the gene which encodes human CaSR have been proven to cause 
a range of disorders associated with an altered response to Ca2+. These include familial 
hypocalciuric hypercalcemia, neonatal hyperparathyroidism and autosomal dominant 
hypocalcemia (Pollak et al. 1994;Pearce et al. 1996).  
CaSR has been shown to influence both parathyroid and renal function (Hebert et al. 1997). 
In the parathyroid the CaSR responds to an increase in extracellular Ca2+ by inhibiting the 
production and secretion of parathyroid hormone (PTH) (Brown et al. 1995). A reduction in 
extracellular Ca2+ causes the CaSR to stimulate synthesis and secretion of PTH. PTH 
mediates skeletal resorption via osteoclast action and also stimulates increased renal 
reabsorption of Ca2+ (Kovacs et al. 1998). The presence of the parathyroid Ca2+ sensing 
receptor was confirmed in human placental cells by the use of reverse transcription PCR and 
northern blot analysis. However, the major transcript varied slightly to that expressed in 
human parathyroid cells (Bradbury et al. 1998).  
The intricacies involved in maternal-fetal Ca2+ homeostasis advocated the exploration of the 
role of fetal CaSR. The use of a CaSR gene knockout mouse allowed for further research 
into fetal Ca2+ handling (Ho et al. 1995). These studies noted that CaSR located in the fetal 
parathyroid gland suppressed PTH secretion in response to the typically high circulating 
Ca2+ levels (Kovacs et al. 1998). The authors found that placental Ca2+ transfer was 
disrupted by alteration to the CaSR. Both CaSR+/- and CaSR-/- fetuses displayed an elevated 
blood Ca2+ level, however whilst the CaSR+/- showed a modest reduction in relative Ca2+ 
transport across the placenta the CaSR-/- fetus displayed a 60% reduction compared to wild 
type counterparts. The authors reasoned that due to the similar increase in circulating fetal 
Ca2+ between genotypes the alteration in the maternal-fetal Ca2+ gradient was not 
responsible for the changes in placental transfer of Ca2+ noted in CaSR-/- (Kovacs et al. 
1998). These findings also point to a compensatory mechanism that allows both genotypes 
to still achieve a hypercalcemic state, possibly due to a change in renal and/or skeletal 
calcium handling. It is thought the role of CaSR in the developing fetus is to suppress the 
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secretion of PTH in response to elevated circulating Ca2+ to maintain the divergence 
between fetal and maternal Ca2+ levels. It is believed that disruption of the CaSR gene 
disturbs fetal Ca2+ homeostasis by affecting PTHrP controlled Ca2+ transport (Kovacs et al. 
1998). 
 
1.4.2.4 TRPV6 Epithelial calcium channel 
 
TRPV6 is the epithelial Ca2+ channel involved in the maternal-fetal transport of Ca2+. These 
Ca2+ specific channels are located on the apical microvillous membrane of the 
syncytiotrophoblast which is exposed to the maternal circulation. Ca2+ diffuses via an 
electrochemical gradient into the cytoplasmic compartment of the syncytium (Haché et al. 
2011). These highly selective Ca2+ channels are part of the TRP super family and once the 
functionality of these proteins was elucidated they were labelled ‘transient receptor potential 
vanilloid’ (TRPV) channels (Harteneck et al. 2000). At present this TRPV subfamily 
comprises of isoforms TRPV5 and TRPV6. Previously, TRPV6 has been shown to act as the 
entry pathway in intestinal Ca2+ transport and is regulated by 1,25 dihydroxyvitamin D 
(Bianco et al. 2007). However TRPV6 was only recently identified in vivo as an important 
contributor in maternal-fetal Ca2+ transport.  Although mRNA expression has been recorded 
in both human and murine placenta (Moreau et al. 2002) the exact physiological role has not 
yet been defined. Wild type mice display a 14-fold increase in placental TRPV6 mRNA over 
the last four days of gestation (term= E21). This coincides with an increase in other Ca2+ 
related transporter proteins that increase to meet fetal demand during fetal skeletal 
mineralisation. It was reported that TRPV6 knockout mice had significantly lower fetal blood 
calcium than wild type counterparts. The authors were able to deduce this hypocalcemia 
was potentially due to a decrease in maternal-fetal calcium transport (Suzuki et al. 2008). 
The TRPV6 knockout mouse also displayed a 40% decrease in radioactively labelled Ca2+ 
transport from the mother to the fetus when compared to their wild type counterparts  
(Suzuki et al. 2008). This measurement was taken in vivo and was the first evidence that 
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TRPV6 is involved in maternal-fetal Ca2+ transport. TRPV6 regulation has been studied 
during pregnancy in both mice and rats using anti-steroid hormone antagonist injections prior 
to maximal TRPV6 expression (Lee et al. 2009). The authors report that down-regulation of 
TRPV6 expression in the rat placenta after treatment with RU486 (a progesterone receptor 
antagonist) indicates that progesterone and its receptors may control placental TRPV6 
transcription. In contrast to this the authors also report that TRPV6 expression in mice may 
be regulated by oestrogen after observing significant down regulation of TRPV6 after the 
introduction of ICI182,780 (an oestrogen receptor antagonist). This indicates that regardless 
of species, TRPV6 may be regulated by sex steroids (Lee et al. 2009).  
 
1.4.2.5 Calbindin-D9k Calcium binding protein 
Calbindin-D9k, with a molecular weight of 9-kDa is considered to be a reliable marker for 
epithelia Ca2+ transport (Morgan et al. 1997). It has two Ca2+-binding domains and is part of 
an intracellular group of proteins which have high affinity for calcium (Christakos et al. 1989). 
These proteins undergo structural changes once binding has occurred. Unlike other Ca2+ 
transporting proteins however, each Ca2+ binding protein is encoded by a different gene and 
there is no association and no homology between separate genes (Persechini et al. 1989). 
Expression has been verified in numerous tissues including uterus, placenta, kidney, 
intestine, bone and pituitary glands (Choi and Jeung 2008). Placental transcripts of 
Calbindin-D9k were found in both the cytotrophoblasts and syncytiotrophoblast of human 
placenta at term. The syncytiotrophoblast had higher levels of expression than the 
cytotrophoblasts (Belkacemi et al. 2004).  Over the last third of gestation there is a marked 
increase in the expression of Calbindin-D9K in both mouse and rat placenta (Mathieu et al. 
1989;Glazier et al. 1992;Hamilton et al. 2000;An et al. 2004;Bond et al. 2008). This up 
regulation of Calbindin-D9K expression in the rat placenta was also linked to an increase in 
unidirectional maternal-fetal Ca2+ clearance over the same period. This led to speculation 
that Calbindin-D9K is rate limiting for the placental transport of Ca2+ in the rat (Glazier et al. 
34 
 
1992). In contrast to this, it is reported that the Calbindin-D9k knockout mouse was 
phenotypically normal and survived for up to a year postnatally suggesting there is a 
compensatory mechanism to cope with Calbindin-D9k deficiency (Lee et al. 2007). Moreover, 
further investigation into Calbindin-D9k null mice showed they were indistinguishable from 
wild-type counter parts in mice in both phenotype and serum Ca2+ levels. The authors 
reason that Calbindin-D9k is not required in reproduction or Ca2+ homeostasis (Kutuzova et 
al. 2006).  
In the mouse placenta regulation and expression of Calbindin-D9k has been shown not to be 
dependent upon the vitamin-D receptor  as has been shown in other tissue (Shamley et al. 
1996). This led to further exploration and studies suggest that Calbindin-D9k mRNA in mouse 
placenta can be regulated by sex steroid hormones E2 and P4 and their receptors via 
complex pathways in the tissue. Furthermore placental control via sex steroid hormones 
versus known vitamin D control of Calbindin-D9k in the intestine allow for speculation that 
Ca2+ binding is regulated in a tissue specific manner (An et al. 2004). It was also reported 
that placental Calbindin-D9k is marginally increased in expression in the PTHrP null fetus 
leading to the conclusion this particular isoform is regulated by PTHrP (Bond et al. 2008). 
The binding of Ca2+ for transcellular transportation between apical and basal membrane 
comes with added benefits. The buffering action of binding, especially in the Ca2+ rich 
trophoblast environment, allows for intracellular Ca2+ to continue in its role as a signalling 
molecule independent from Ca2+ transport (Koster et al. 1995).  
It should been noted that Calbindin-D9K concentration in Ca2+ transporting epithelia is often 
in the sub-millimolar range to complete its normal function (Feher 1983) and therefore 
accounts for the abnormally large increase seen in placental Calbindin-D9k in the last 
trimester of pregnancy. Interestingly studies have shown a remarkable co-localisation of 
Calbindin-D9K in any tissue expressing TRPV5/6 Ca2+ channels and this could suggest a 
functional coexistence that is yet to be deliberated (Lambers et al. 2006). It is plausible that 
Ca2+ binding is happening close to the channel entrance to maintain a Ca2+ gradient and 
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thus influx. It must also be taken into consideration however that there may be a functional 
interaction between the two proteins that needs exploring (Shimura and Wasserman 1984). 
 
1.4.2.6 Plasma membrane calcium ATPase 
PMCA plays a key role in the active extrusion of intracellular Ca2+ from the cell. In the 
placenta PMCA is located on the basal membrane of the syncytium. It was thought that 
PMCA was exclusive to the BM however it has been reported more recently that isoforms 
are found on the MVM. It also been reported that the PMCA localised to the MVM 
demonstrates higher activity and expression than that on the BM (Marín et al. 2008). In the 
BM, PMCA is the primary transporter mediating the extrusion of calcium out of the cell 
(Fisher et al. 1987;Strid et al. 2003). Four separate genes have been identified (PMCA1-4) 
which code PMCA (Zylińska et al. 2002). Isoforms 1 and 4 are expressed ubiquitously in all 
tissues, whereas isoforms 2 and 3 are found in more specialised cell types (Zylińska et al. 
2002). To be functional, PMCA requires the presence of ATP. Due to its importance in the 
transcellular transport of Ca2+, PMCA has been widely studied. In rat placenta a three-fold 
increase of PMCA gene expression was recorded which led to a 72-fold increase in total 
Ca2+ across the placenta in the final days of gestation (Glazier et al. 1992).  
1.4.3 PLACENTAL CALCIUM TRANSPORT AND PREGNANCY COMPLICATIONS  
A study conducted in placentas from IUGR fetuses showed PMCA activity was increased by 
48% whilst  expression was reduced by 15% when compared to controls (Strid et al. 2003) . 
Using rapid filtration techniques to quantify the transport activity of Ca2+ into human 
syncytiotrophoblast basal plasma membrane vesicles, it was hypothesised that PMCA 
activity may be activated by IUGR.  The ability of IUGR to alter the expression and activity of 
PMCA in the placenta supports suggestions that the placenta can respond to fetal demand 
growth signals through regulation and expression of specific placental transport systems  
(Constancia et al. 2005). 
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IUGR can be a consequence of preeclampsia, which is characterised by gestational 
hypertension, proteinuria, oedema and fetal syndromes. Although the exact pathogenesis of 
pre-eclampsia remains unclear it is considered to involve systemic failings (Sibai et al. 
2005). Placentas of women with pre-eclampsia have been shown to have reduced 
expression of isoforms 1 and 4 of PMCA (Haché et al. 2011). Due to the afore mentioned 
dependency on the presence of ATP to remain functional,  previous studies have shown that 
pre-eclamptic placental cells display lower ATP levels due to an alteration in a ATP-synthase 
gene (Hansson et al. 2006). In rat cells it has been shown that changes in PMCA expression 
correlate with its activity and ATP content (Nabekura et al. 2004). In term labour monitored 
for key pre-eclamptic marker soluble fms-like tyrosine kinase-1, it was recorded that TRPV6 
and PMCA were highly expressed in both maternal and fetal sections of the placenta, the 
authors deduced this may be in reaction to impaired Ca2+ metabolism across the 
syncytiotrophoblast to maintain fetal and maternal Ca2+ balance (Yang et al. 2013).  
 
1.5 IN VIVO AND IN VITRO MODELS OF THE PLACENTA 
The use of in vivo and in vitro models provides the ideal conditions in which scientific 
experiments can be conducted, although all results must be considered in the context of said 
conditions.  
1.5.1IN VIVO RAT MODEL OF PREGNANCY AND PLACENTAL FUNCTION 
Both human and rat placenta are of a haemochorial nature which involves the modification of 
the maternal-fetal interface in order to accommodate nutrient transport to the developing 
fetus which is achieved in two stages. Firstly, nutrients from maternal circulation must be 
delivered to the placenta. Secondly, nutrients must be transferred from the placenta to the 
fetal compartment. To fulfil these requirements both species undergo extensive vascular 
remodelling of maternal spiral arteries as described in section 1.3 (Pijnenborg et al. 1981). 
Other similarities appear in the placental to fetal interface in which a syncytial barrier is 
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formed, the rat placenta utilises a hemotrichorial barrier which comprises of three 
trophoblastic layers whereas the human barrier is of hemomonochorial descent. 
Organisationally, there is variation in the trophoblastic make up. The human placenta utilises 
the syncytial trophoblastic layer on the maternal side with the cytotrophoblast layer localised 
to the fetal blood side of the cell. The rat placenta is different in that the cytotrophoblast layer 
is localised to the maternal side of the membrane and there are two syncytial trophoblast 
layers (Knipp et al. 1999). In both cases, however, the uterine-placental interface is also 
characterised by trophoblastic invasion of uterine tissue (Soares et al. 2012).  In the human 
placenta the cytotrophoblast and syncytiotrophoblast cells are found in both villous and extra 
villous locations.  In the rat, cells of the trophoblastic lineage are very zone specific - 
trophoblast giant cells are located in the junctional zone and the labyrinthine whereas the 
spongiotrophoblasts and the syncytial trophoblast cells are located only within the junctional 
zone and labyrinth zone respectively (Knipp et al. 1999).  
In human gestation the placenta continually gets bigger as gestation progresses. Although 
the rate of growth slows in the last few weeks, villous tree development and branching, 
increase in exchange surface areas and DNA synthesis have all been found up until 42 
weeks of gestation (Fox 1997). The rodent placenta, however, reaches it largest size at mid 
to late gestation and begins to decrease towards term as the rapid growth of the fetus at 
term utilises placental energy and nutrient stores (Coan et al. 2004).  
Although transport of calcium and amino acids across the rodent and human placenta are 
well characterised (Glazier et al. 1992;Dilworth et al. 2010;Bond et al. 2008) there are 
notable differences in the rodent. The intra placental yolk sac is found exclusively in the 
rodent placenta and has previously been shown to express higher levels of calbindin-D9k 
than surrounding trophoblasts (Bruns et al. 1985). Subsequently, the increased expression 
of calcium transporting proteins recorded in the rodent placenta towards the later stages of 
gestation is mirrored in the intra placental yolk sac which leads to a larger increase in 
calbindin-D9k than recorded in trophoblasts (Mathieu et al. 1989). Further to this the intra 
placental yolk sac has also been shown to express PMCA (Borke et al. 1989).  
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The rat is a well characterised model of human pregnancy with similarities in placental 
structure and function to those seen in the human placenta. However, as with any model, 
differences will ultimately cause limitations when translating data interpretation between the 
rat and human.   
1.5.2 IN VITRO CELLULAR MODEL OF THE PLACENTA: BEWO  
BeWo are a human cell line that originated from a choriocarcinoma which was first isolated 
over 40 years ago (Pattillo and Gey 1968). Cells were initially separated and transferred to 
the cheek pouch of a hamster before being placed in co-culture with human decidual 
explants (Pattillo and Gey 1968). They have since been maintained as a continuous 
immortal cell line for a placental in vitro model. BeWo cells retain the endocrine function of 
trophoblastic cells in that they secrete hCG and hPL. These hormones used to be the criteria 
for identification as a trophoblast cell type; however it is now clear that other non-
trophoblastic cell lines also produce hCG (Duffy 2001). The new standard relies on the 
expression of cytokeratin-7, HLAG or CD9, markers which correspond to trophoblastic and 
extravillous cell types, of which BeWo express two and thus this cell line is a mix population 
of cells (Sullivan 2004).  
Isolated human placental cell lines retain many morphological aspects of in vivo trophoblast 
cells and BeWo are no exception. They resemble both undifferentiated cytotrophoblasts and 
syncytialised trophoblast cells (Wolfe 2006). Continuous cell culture models are often used 
in experiments as they infer benefits that in vivo work or isolated primary cells cannot.  
BeWo cells are used in trans-cellular studies over isolated placental fragments or primary 
cells because they do not spontaneously syncytialise and leave gaps on the growing surface 
(Jones et al. 2006a).  BeWo cells are utilised in a range of placental function experiments 
including, but not limited to; effects of xenobiotics, endocrine function, trans-placental 
transfer, cellular efflux and transporter elucidation experiments (Myllynen and Vähäkangas 
2013). Another benefit of using a cell-line is that you are able to conduct experiments on 
single cell types without having other placental cell types affecting results.  
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Choriocarcinoma cell lines also have disadvantages; it is uncertain what effect that other 
placental cell types can have on the function of trophoblasts and by removing them from a 
whole placental environment you may be altering the behaviour that would be seen in vivo. 
Furthermore, BeWo lack the function of some nutrient transporters and some argue it is 
difficult to extrapolate data obtained using cell lines into an in vivo context (Kitano et al. 
2004). Further complications arise when the longevity of the cell line comes into 
consideration; different laboratories report intra-BeWo variation with regards to fusion rates 
and syncytialisation. It has previously been reported that trophoblast cell lines in culture can 
undergo phenotypic drift when kept in sub optimal conditions thus leading to a change of 
characteristics (Orendi et al. 2011).  
1.6 CIRCADIAN RHYTHMS 
Physiological and behavioural processes have adapted to be cyclical in nature to allow 
organisms to more effectively cope with predictable daily fluctuations in the external 
environment. Oscillations in function are driven by endogenous biological clocks which are 
found system wide and co-ordinate a variety of physiological processes to align with 
behaviour; these include cell proliferation and metabolism (Asher and Schibler 2011). The 
advantage of maintaining a molecular clock is still disputed, however it has been shown that 
under selective pressure simple organisms garner a fitness advantage with functioning and 
suitable circadian machinery.  
 It has been shown that cyanobacteria outgrow competitors in an environment that is specific 
to the period length of their circadian oscillations (Woelfle et al. 2004). In organisms of a 
more complex nature it is now widely accepted that disruptions to circadian function and 
gene mutations can lead to infertility and cancer (Fu et al. 2002). It is agreed that the 
hypothalamus is the home of the mammals circadian timing system (Rusak and Zucker 
1979), named the suprachiasmatic nucleus (SCN). Work conducted specifically on the SCN 
has shown that isolation of a single neuron does not disrupt its ability to generate a circadian 
oscillation (Michel et al. 1993). This lead to the hypothesis that rather than being responsible 
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for the generation of circadian rhythms organism wide, the SCN acts to regulate, 
synchronize and orchestrate circadian rhythms via peripheral clocks located in almost every 
tissue including the placenta (Wharfe et al. 2011).  
Light/dark cycles entrain the SCN via light receptive ganglion cells located in the retina 
(Lowrey and Takahashi 2000) and in turn peripheral oscillations are synchronised by 
endocrine and autonomic action governed by the SCN (Hastings et al. 2007). Work 
conducted using an implanted SCN in porous plastic was able to reverse the abolition of 
circadian oscillations in animals which had lesions on the SCN. This was the first evidence to 
suggest that circadian cues were primarily hormonal rather than electrical as was previously 
thought (Silver et al. 1996). Further work conducted using immortalised cell lines in culture, 
demonstrated the ability of the serum shocking technique to synchronise the cells circadian 
machinery in 35 year old rat fibroblasts. Serum shocking is postulated to work in 1 of 2 ways, 
firstly, un-synchronised cell circadian rhythms are re-synchronised by the addition of the high 
concentration serum media, or secondly; the serum shock technique works to kick start 
dormant rhythms in isolated cells. This work was the beginning of a range of experiments 
which demonstate that detailed circadian machinery is in fact ubiquitous to most tissues of 
the mammalian body (Balsalobre et al. 1998).  
Synchronisation is thought to happen in a hierarchical manner. External timing cues, 
predominantly light, entrain the central timing machinery or pacemaker. The SCN contains 
independently cycling neurons that subsequently project the entrained rhythm into the 
autonomous peripheral tissue’s circadian machinery (Kowalska and Brown 2007). Despite 
increased understanding into the workings of the molecular clock, the way in which it 
influences physiological behaviour and gene expression remains unknown. Current research 
suggests the SCN communicates with peripheral circadian machinery through several 
different pathways and mechanisms. Peripheral circadian machinery can directly control 
gene expression via transcription factor cascades.  
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1.6.1 CLOCK GENES  
It is now widely agreed that peripheral clocks control gene expression and physiology rather 
than the master clock in the SCN (Kowalska and Brown 2007).These central and peripheral 
circadian systems are made up of a network of ‘clock’ genes, including CLOCK, BMAL1, 
Per1-3, Cry1 and 2. These genes form complicated feedback loops using transcriptional and 
translational processes to drive oscillating rhythmic expression of downstream genes, thus 
leading to rhythmic patterns in physiological processes.  
Elucidation of the workings of clock machinery was undertaken after the mapping of 
circadian genes using N-ethyl-N-nitrosourea (ENU) mutagenesis (Vitaterna et al. 1994). 
CLOCK and BMAL1 form the positive limb of the transcriptional feedback loop. CLOCK and 
BMAL1 undergo transcription and translation and the proteins pool in the cell cytoplasm. 
CLOCK proteins undergo post translational modifications to increase stability and cellular 
localisations to maintain accuracy of the circadian machinery. It also acts to delay feedback 
inhibition by the negative limb by delaying transcriptional activation (Chen et al. 
2009;Gallego and Virshup 2007). CLOCK and BMAL1 then interact to form a heterodimer in 
the cell cytoplasm. Once the CLOCK/BMAL1 dimer is constructed the formation moves back 
into the nucleus via BMAL1 shuttling.  
Studies have shown that BMAL1 contains a functional nuclear localisation signal in the N-
terminal, this means BMAL1 is crucial to a functioning circadian oscillation as it allows the 
CLOCK/BMAL1 complex to aggregate to the cell nucleus (Kwon et al. 2006). It is the 
shuttling of the CLOCK/BMAL1 protein heterodimer which is key in driving circadian 
oscillations. The post translational events, including the stabilisation of CLOCK and the 
shuttling of BMAL1 are key and have been described as the activators of the mammalian 
clock system (Kondratov et al. 2003).  
Once in the nucleus the CLOCK/BMAL1 heterodimer interacts with an E-Box enhancer 
element - a DNA sequence that can act as a protein binding site (Hao et al. 1997) - on the 
promoters of circadian controlled genes to drive the expression of all other core clock genes 
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(Li et al. 2012) Include Cry and Per. These proteins act as the negative agents in the 
feedback loop. At this point the expression of Per and Cry proteins is increased and they 
interact in a similar fashion and translocate in to the nucleus to inhibit the activity of CLOCK 
and BMAL leading to degradation of the formed heterodimers in the nucleus. Consequently, 
there is a decrease in stimulation of core clock gene production (Hirota et al. 2002). After the 
inhibition of the CLOCK/BMAL1 heterodimer via the action of Cry and Per, circadian gene 
expression is no longer driven by the binding of CLOCK/BMAL1 to the E-Box enhancer 
elements on the genes. As such, Cry and Per are no longer there to inhibit CLOCK/BMAL1 
action and thus the transcription translation oscillating loop is formed. This has become 
known as the transcription translation oscillating loop model (TTO). 
1.6.2 TTO AND CORE CLOCK GENES 
Other proteins have been identified as accessory proteins. These include; D-Box binding 
proteins, the retinoid-related orphan receptor and the nuclear receptor subfamily 1. These 
accessory proteins are all thought to support and modulate the activity of the TTO loop 
(Richards and Gumz 2012). 
Although the same basic components in the central and peripheral circadian systems are 
both capable of generating oscillations, it has been noted that mutations in circadian genes 
have exaggerated effects within peripheral tissues. It has been shown that deletion of the 
Per1 gene decreases the period of a circadian oscillation by approximately an hour yet in 
isolated fibroblasts the same deletion causes a four hour discrepancy (Brown et al. 2005). In 
contrast to this, it has been recently reported that the abolition of CLOCK does not disrupt 
circadian behaviour. It is postulated that other proteins are able to substitute in order to 
retain function. Some peripheral tissues may not express these substitute proteins leading to 
a bigger discrepancy in peripheral circadian oscillations compared to the SCN (Debruyne et 
al. 2006). In addition to this, it has been reported that there is greater neuronal coupling in 
the SCN compared to peripheral counterparts resulting in better intracellular communication 
and thus better adherence to the circadian clock (Welsh et al. 2004). 
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1.6.3. DIETARY CUES OF THE CIRCADIAN CLOCK 
How diet and feeding cues can influence the circadian clock has come under close scrutiny 
in recent years.  The synchronicity of the CLOCK and BMAL1 regulation has been shown to 
be directly involved with glucose homeostasis. The inactivation of CLOCK and BMAL1 leads 
to the daily variation in the concentration of glucose and triglycerides. Gluconeogenesis is 
reported to be down regulated in CLOCK mutants, whereas it is totally abolished by deletion 
of the BMAL1 gene (Rudic et al. 2004). It is possible that CLOCK or BMAL1 may also work 
independently of the circadian clock mechanism to exert effects elsewhere. This must be 
considered when using knockout mice models to elucidate the function of the circadian clock 
(Rudic et al. 2004).  Investigation into how diet can influence the circadian clock has found 
that a high fat diet is able to manipulate circadian variation by changing carbohydrate 
metabolism (Kohsaka et al. 2007).  
Maintenance of blood glucose levels has always been critical to mammalian survival and it 
has been demonstrated that CLOCK and BMAL1 contribute to recovery from the 
hypoglycaemic response to insulin. Changes in feeding patterns have also been noted to 
shift the circadian gene expression in peripheral clocks. It was shown that alterations to 
feeding patterns brought about a change in circadian gene expression in the liver which was 
not seen in the master clock in the SCN (Damiola et al. 2000). Glucose was also able to 
induce a rhythmic oscillation of gene expression in isolated fibroblasts (Hirota et al. 2002). 
More recent studies have also examined the role the circadian clock plays in glucose 
homeostasis; investigators reported a delayed circadian oscillation in glucose metabolism 
and insulin signalling in circadian mutants (Marcheva et al. 2010). Pancreatic islets were 
shown to express peripheral circadian machinery and CLOCK disruptions led to 
transcriptome wide changes in growth and survival (Marcheva et al. 2010). As with all 
homeostatic processes the circadian machinery is not the only mechanism exerting its 
effects upon the regulation of glucose and it works in conjunction with other processes such 
as steroids, epinephrine and glucagon (Hochgeschwender et al. 2003). 
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Although recent studies have highlighted how circadian oscillations can impact behaviour 
and cell physiology, it is still hard to envisage the potential of circadian study to characterise 
human disorders. Maintenance of a subject under control conditions is costly and even 
though some peripheral tissues are widely available; namely blood, hair and skin, the nature 
of peripheral oscillations and circadian machinery results in the tissues not being functional 
for studies of pathologies that do not take place in these tissues. 
1.6.4. CIRCADIAN ACTIVITY IN THE PLACENTA 
Rhythmic placental activity has previously been observed in the rat when analysing fetal 
growth rate. It was noted that two-thirds of total daily dry and wet fetal weight was gained 
during the active (dark) phase of the rats daily routine (Barr 1973). Although this observation 
was in part due to the maternal circadian behaviour of the mother, it does suggest the 
placenta may display rhythmic activity. Recent reports indicate that disruption to normal light-
dark cycles can reduce fetal growth in the rat by up to 24% at term (Gozeri et al. 2008). 
These altered light schedules that the rat was exposed to resulted in abnormal placental 
histology. This included an increase in placental oedema, fibrin accumulation and leukocyte 
infiltration. A somewhat more tenuous link between altered circadian behaviour and adverse 
fetal outcome in humans has been made when looking at both regular air travel and shift 
work during pregnancy. Low birth weight and pre-term birth both have both been associated 
with these activities (Mahoney 2010).  
In the extravillous trophoblast cell line HTR-8/SVneo oscillatory expression of Per2 and Vegf 
occurred after a serum shock procedure which has been shown to induce cyclic expression 
of clock genes in other tissues (Balsalobre et al. 1998;Frigato et al. 2009). However, there 
are no reports of cyclic circadian activity in the intact human placenta. In rodent models, 
circadian oscillations have been recorded in the placenta for several clock genes. The 
expression of said genes was noted to be very zone specific. The labyrinthine zone of the 
placenta expressed higher levels of CLOCK, whereas the junctional zone was recorded to 
have increased BMAL1 levels (Wharfe et al. 2011). The relative amplitude recorded during 
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the cyclic activity was very low in the mouse and in the rat the cyclic activity was very phase 
dependent however all clock genes peaked in the dark phase (Wharfe et al. 2011). This is at 
odds with other tissues that display circadian variation where the afore mentioned feedback 
loops drive cyclic expression (Hastings et al. 2007). 
Despite clear evidence that the placenta does express clock genes, the impact they have on 
placental function is still unclear. There is a need for specific studies that look into the effect 
that circadian machinery has on the placenta and pregnancy outcome. 
1.7 SUMMARY AND AIMS 
A religious period of IF can sometimes coincide with pregnancy. Although women are 
exempt from the fasting period many choose to participate on social grounds. It was noted 
that a period of fasting during specific trimesters of gestation lead to a reduced placental size 
at term. The placenta however was able to maintain fetal growth so there was no disparity 
between fetal sizes at term. To this end the placenta must be able to meet fetal demand 
signals via the transfer of nutrients from the maternal blood to the fetal compartment. 
Healthy structural developments of the nutrient transporting zones in the placenta are key to 
this and it is the syncytiotrophoblast that is primarily responsible for nutrient transfer. Both 
calcium and amino acid transport must be maintained from the beginning of gestation until 
term at the normal rate as both have previously been linked to altered fetal outcome.  
Another aspect of IF that challenges placenta function is the altered dietary cues and 
sleeping pattern which arise from the fasting period. Placental circadian regulation has not 
been widely explored especially with regards to the nutrient transporting capabilities of the 
syncytiotrophoblast. 
A review of current literature has highlighted a disparity between the amount of women 
participating in IF during gestation and our understanding of the impact it may have on both 
normal placental development and fetal outcome. The aims of this study are to establish an 
in vivo IF model in the rat and characterise changes in protein expression of key nutrient 
transporting proteins for calcium and amino acids, and the regulatory proteins involved with 
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the circadian clock. The report then goes on to investigate the localisation of circadian 
machinery in the main nutrient transporting zone of the human placenta using the human 
choriocarcinoma cell line BeWo and looks to establish a link between circadian oscillations 
and the protein expression of key nutrient transporters.  
It is important that we document changes that could occur in placental development/function 
due to a period of IF. The information will allow women to make informed decisions with 
regards to the development of the fetus or it may lead to possible dietary supplementation to 
assist fetal development during the IF period.  
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CHAPTER 2: MATERIALS AND METHODS 
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2.1 MATERIALS 
All reagents were purchased from Sigma-Aldrich, Dorset, UK unless specified otherwise. 
Animal work described in sections 2.2.1 was conducted by Dr N. Ashton and colleagues at 
the University of Manchester, UK. 
2.2 INTERMITTENT FASTING ANIMAL STUDY 
2.2.1 ANIMALS AND HUSBANDRY 
All experiments were performed in accordance with the UK Animals (Scientific Procedures) 
Act of 1986. Wistar female rats (sourced from Charles River United Kingdom (CRUK)) were 
housed in Biological Services Unit (Stopford Building, Manchester) in a 12:12 hour light-dark 
cycle between 21-23ºC with unlimited water supply. Females were mated with male studs 
with pregnancy day E0 defined as the presence of copulation plug. Intermittently fasted rats 
(n=9) had access to food denied from 5pm-9am daily throughout gestation whereas control 
counterparts (n=11) had unlimited access to standard pellet chow (Beekay Rat and Mouse 
Diet; Bantin and Kingman; Hull, UK). Dams were culled at term (E21) by Schedule 1 
techniques and placentas were harvested from the uterine horn. One randomly assigned 
placenta from each litter was individually snap frozen in liquid nitrogen and stored at -80˚C 
until required. Food intake and maternal weight was recorded daily from gestation until term. 
At E21 both fetal and placental weight was recorded.  
2.2.2 HOMOGENISATION OF PLACENTAL TISSUE 
Individual placentas were placed into a 55ml dounce homogenizer (Fisher Scientific, 
Loughborough, UK) with ice cold 1% PIC-RIPA buffer (homogenisation buffer). Samples 
were treated with 1ml homogenisation buffer per 0.1g of tissue. Tissue samples were 
homogenised on ice and prepared samples were transferred to 15ml falcon tubes (Fisher) 
and centrifuged at 2500g (MSE Mistral 3000i Centrifuge, London, UK) at 4˚C for 5 minutes. 
The post nuclear supernatant (PNS) was drained; half was frozen at -80˚C in 1.5ml Micro-
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centrifuge tubes (Fisher). To obtain the cytoplasmic fraction the remaining PNS was 
transferred to Beckman Ultracentrifugation tubes and spun at 100,000g  for 1 hour at 4˚C 
(Beckman-Coulter Optima L-100K Ultracentrifuge, High Wycombe, UK). The PNS was 
discarded and the pellet re-suspended in 100µl of homogenisation buffer to acquire the 
membrane fraction. Samples were then stored at -80˚C in 0.5ml micro-centrifuge tubes 
(Fisher) until used. 
2.2.3 PROTEIN QUANTIFICATION 
Protein concentration of homogenised rat placental samples was calculated using the 
Bradford’s micro plate assay method (Bradford 1976). Known BSA protein concentrations (0-
1000µg/ml) were used to construct a standard curve off which placental samples could be 
read to determine protein concentration. Placental homogenates were diluted 1 in 40 before 
standards and samples were pipetted onto a 96 well plate (Costar Cambridge, MA USA). 
200µl of Bradford’s reagent (at room temperature) was mixed into all wells before the optical 
density (OD) was measured at 595nm using a FLUOstar OPTIMA plate reader (BMG 
Labtech GmBH, Offenburg, Germany). MARS Analysis software was used to determine 
protein concentrations. 
 
Protein 
Concentration 
µg/ml 
BSA mg/ml (µl) DH2O (µl) Bradford’s Reagent (µl) 
0 0 10 200 
200 2 8 200 
400 4 6 200 
600 6 4 200 
800 8 2 200 
1000 10 0 200 
Table 2.2: BSA concentrations used to construct a standard curve. 
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2.2.4 GEL ELECTROPHORESIS 
Protein extracted from rat placental samples (20-50 µg) was loaded on to a polyacrylamide 
bis tris gel (4-12% or 12%; Invitrogen Ltd., Paisley, UK) after the addition of 4x sample buffer 
(Invitrogen Ltd.) and DH2O. In some cases samples were heated at 70˚C for 10 minutes 
and/or reduced via the addition of 500 mM dithiothreitol reducing agent (Invitrogen Ltd.) 
(table 2.3). 10µl of pre-stained protein standard (3.5-260kDa; Invitrogen Ltd.) was also 
loaded into a single well on each gel. Gels were then subjected to vertical electrophoresis 
using a X-cell II system (Invitrogen Ltd.) in 1xMES running buffer (Invitrogen Ltd.) at 200V 
and 400mA until sufficient protein migration was observed.  
2.2.5 ELECTRO-BLOTTING 
Separated proteins were blotted on to polyvinylidine fluoride (PVDF) membrane (Millipore, 
Watford, UK) using the X-cell II system. The gel-membrane assembly was constructed as 
shown in figure 2.2 using Whatmans grade 4 filter paper. Proteins were transferred for 90 
minutes at 30V and 400mA in cold transfer buffer (1.45g Tris base, 7.2g glycine, 200ml 
methanol and 800ml dH2O). The blotting process was conducted on ice.  
 
2.2.6 PROBING THE MEMBRANE 
Membranes were blocked using specific concentrations of non-fat milk powder (Sainsbury’s, 
UK) and Tween-20 diluted in either PBS or TBS (Table 2.3; 1.21g Tris, 8.18g sodium 
chloride, 1l DH2O, pH7.4) for 30 mins at 4˚C. Membranes were then subjected to overnight 
incubation with primary antibodies at 4˚C with gentle agitation. Appropriate secondary 
antibody washing was then conducted using either Goat Anti-Rabbit or Goat Anti-Mouse 
conjugates at a dilution of 1:5000 in the relevant antibody buffer shown in table 2.4. All 
membranes were probed with β-Actin to ensure equal protein loading. 
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Figure 2.2: Gel/Membrane complex used in the Western blot procedure. 
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2.3 CULTURING OF FIRST TRIMESTER CHORIOCARCINOMA CELL LINE, BEWO 
2.3.1 BEWO 
The BeWo (ATCC® CCL-98™) (passages 2-9) cell line was grown in 10, 17, 20, 30 or 
45mmol/l glucose Dulbecco’s Modified Eagles Media (DMEM). Medium was supplemented 
with 10% fetal bovine serum (FBS) and 2% Penicillin-Streptomycin. BeWo cells were 
cultured in media containing 17mmol/l glucose unless it is specifically stated in the 
methodologies otherwise. A personal communication (Dr Westwood M, Dr. Forbes K and 
Prof. Aplin JD; Maternal and Fetal Health Centre, University of Manchester) indicates 
placental trophoblast cells are commonly cultured in a media with a supra-physiological 
concentration of glucose measuring 17mmol/l. This is possibly due to the high glucose 
consumption that occurs in BeWo.  The cells were incubated at 37˚C with 5% carbon dioxide 
(CO2)/air and 100% humidity and the culture media was replaced every 48 hours.  
2.3.2 FREEZING AND THAWING OF CHORIOCARCINOMA BEWO CELLS 
BeWo cells were given fresh media 24 hours prior to freezing. Confluent cells were 
trypsinised and incubated at 37˚C for 5 minutes to detach cells from the bottom of the culture 
flask. The 0.05% trypsin/EDTA solution was deactivated by the addition of fresh culture 
media. The resultant cell suspension was centrifuged (1000g for 5 min) and the supernatant 
was removed. The pellet was re-suspended in cold cell culture media (supplemented with 
10% dimethyl sulphoxide (DMSO) and 20% FBS) at a density of 3x106cells per cryo-vial. 
Cryo-vials were kept in a ‘Mr. Frosty’ freezing container at -80˚C overnight before being 
transferred to a liquid nitrogen store at (-176˚C) until required. The ‘Mr. Frosty’ helps avoid 
the formation of ice crystals via the use of isopropanol, which cools at a rate of 1˚C per 
minute, thus reducing cell lysis. 
 Rapid thawing of cells was required to avoid damage because DMSO becomes toxic 
to cells when above 4˚C. Cryo-vials were quickly thawed using a 37˚C water bath, cold cell 
culture media was added, the cell suspensions were centrifuged (1000g for 5 min) and the 
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supernatant was removed. The pellet was re-suspended in fresh media and transferred to a 
25cm2 culture flask. Once confluent, the entire cell population was transferred to a 75cm2 
flask and normal passage procedure was followed thereafter.  
2.3.3 CELL PASSAGE 
BeWo cells were sub-cultured to 80% confluence or above in 75 cm2 culture flasks and once 
confluent they were transferred to a new culture flask or plate. Spent media was removed 
and cells were washed 3 times with Dulbecco’s PBS (-Mg2+ and –Ca2+) to remove media and 
left over serum. Once washed, cells were subjected to 0.05% trypsin/EDTA solution at 37˚C 
for 5 minutes. Trypsin was then deactivated with the addition of fresh culture media (10% 
FBS, 2% pen-strep). The resultant cell suspension was subsequently dispersed via repeat 
gentle pipetting, split into the desired number of aliquots and transferred to new culture 
flasks or plates with fresh media.  
2.3.4 SEEDING DENSITIES 
For experimental work using BeWo cells, 75cm2 and 25cm2 flasks were seeded at 0.1x106 
cells per ml, whereas 96 well plates were seeded at 0.01x106 cells per ml. 
2.3.5 DETERMINATION OF CELL NUMBER 
Following growth of cells in 75cm2 culture flasks, sub confluent cells were harvested using 
0.05% trypsin/EDTA and cells were manually counted using a haemocytometer and phase 
shift microscopy. Cells were counted using the haemocytometer via a glass gridded slide 
consisting of two chambers, each divided into nine 1x1mm squares. A glass cover slip was 
placed over the grid. Cell suspensions were loaded into the described chambers via capillary 
action. The cells occupy the space above the grid in a volume of 0.1µl for each 1 x 1mm 
square and were counted manually and the average cell number was calculated. 
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2.3.6 VIABILITY ASSAY 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assay utilises 
cellular enzymes that reduce MTT to its insoluble configuration formazan, which is purple in 
colour. 2g of MTT was added to 400ml ultra-pure H2O (5g/L), the subsequent solution was 
gravity filtered and then subjected to sterile filtration via syringe action using 0.22µm pore 
size. The relevant fresh cell culture media was made up to 10% MTT. 200µl of the 
media/MTT solution was added to each well on 96 well plates. The plates were then 
incubated for 4 hours at 37˚C, with 5% carbon dioxide (CO2) and constant humidity. Once 
complete media/MTT solution was drained and 150µl of DMSO was added to each well. 
Absorbance was then read using a Tecan Infinite® F50 Robotic plate reader (Tecan Group 
Ltd., Switzerland) with UV at 540nm. 
2.3.7 GLUCOSE CONCENTRATION ON BEWO 
All experiments were conducted at passage 9, prior to that BeWo cells were cultured in the 
relevant media; 10, 20 30 or 45mmol/l glucose, seeded as described in 2.3.4, in 75cm2 
culture flasks. Cells were incubated at 37˚C, with 5% CO2/air and constant humidity until 
confluence was achieved. Once confluent whole cell lysate and nuclei fractions were 
isolated as described below. This experiment was undertaken to ascertain whether BeWo 
cells contained functioning key circadian regulators. These particular glucose concentrations 
were used based upon studies previously conducted and their effects upon BeWo growth 
and confluency. 
2.3.8 SERUM SHOCK PROCEDURE 
Cells were seeded as described in 2.3.4 in 25cm2 tissue culture flasks and grown until 
confluence was achieved. At this stage cells were washed twice with PBS before all liquid 
was carefully aspirated. 4ml of serum shocking media, 17mmol/l glucose DMEM media 
comprising of 50% horse serum 2% penicillin-streptomycin, was added to each flask. BeWo 
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cells were incubated 37˚C  with 5% carbon dioxide and constant 100% humidity for 2 hours in 
the ‘serum shock’ media. Once this 2 hour period was complete media was aspirated off and 
cells washed twice with PBS. Once PBS washes were complete this was considered as time 
0 (T0). 4ml of serum free 17mmol/l glucose DMEM 2% penicillin-streptomycin was then 
added to each flask and cells were harvested every 6 hours for a period of 48 hours. Control 
flasks were subjected to the same wash routine, however they were always incubated with 
10% fetal bovine serum (FBS) and 2% Penicillin-Streptomycin. 
2.3.9 COLLECTION OF WHOLE CELL LYSATE 
Media was carefully aspirated from flasks and cells were washed twice with ice cold PBS. 
This was then drained and ice cold 1% PIC-RIPA buffer was added to flasks. Cells were 
detached from the bottom of culture flasks via cell scraping (Sarstedt, UK). The resulting cell 
suspension was transferred to micro centrifuge tubes and spun at 10,000g for 10 minutes at 
4˚C. The supernatant was carefully removed and stored as whole cell lysate at -80˚C until 
required for further analysis. 
2.3.10 NUCLEI ISOLATION 
Nuclei isolation was conducted using Sigma’s EZ prep kit. Confluent cells in either 25cm2 or 
75cm2 tissue culture flasks were placed on ice and washed with 10ml ice cold PBS before 
the careful aspiration of the wash solution. 4ml of ice cold Nuclei EZ lysis buffer was added 
to the flasks. Cells were harvested and lysed via cell scraping and the entire cell lysate was 
transferred to a separate 15ml centrifuge tube. The solution was vortexed for 10 seconds 
and set on ice for 5 minutes. Nuclei were collected from the solution by gentle centrifugation, 
500g for 5 minutes at 4°C, and the pellet was kept on ice. The supernatant was carefully 
aspirated off and saved as the cytoplasmic fraction for later use. The nuclei pellet was re-
suspended in a further 4ml of Nuclei EZ lysis buffer as follows; firstly 0.5ml was added and 
the solution was briefly vortexed for 10 seconds. Secondly, the remaining 3.5ml of Nuclei EZ 
lysis buffer was added and the solution was vortex mixed for a further 10 seconds before the 
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entire solution was set on ice for 5 minutes. Nuclei were once again collected via gentle 
centrifugation at 500g for 5 minutes at 4°C and the supernatant was carefully aspirated off. 
The nuclei pellet was re-suspended in 200µl of cold Nuclei EZ storage buffer with clumps of 
nuclei being broken up via slow trituration with a micropipette. The final nuclei suspension 
buffer was transferred to micro centrifuge tubes for storage and further analysis.  
2.3.11 TRYPAN BLUE NUCLEI QUALITY ASSAY 
The purity of the final nuclei yield was determined using a trypan blue assay and visual 
microscopic inspection. As the Nuclei EZ storage buffer used in section 2.3.10 contains 
glycerol, nuclei would swell if diluted in an aqueous solution therefore a 30% glycerol 
solution was used. 3ml of glycerol was diluted in 7ml of DH2O and trypan blue 0.4% was 
added at a ratio of 4:1 glycerol solution-trypan blue. Nuclei in storage buffer were then added 
again at a ratio of 4:1 trypan blue glycerol solution-nuclei in storage buffer solution. This was 
then pipetted on to a haemocytometer and inspected using microscopy (EVOSXL Core, Life 
technologies, UK). 
2.3.12 NUCLEI SONICATION 
Nuclei sonication was used to disrupt DNA and nuclear envelopes in order to make the 
solution less viscous. The nuclei solution was sonicated at 70% amplitude for a total time of 
2 minutes, 10 second pulse with 5 seconds off on ice.   
2.3.13 WESTERN BLOTTING OF BEWO WHOLE CELL LYSATE AND NUCLEI 
FRACTIONS 
BeWo whole cell lysates were subjected to the same procedures described between 2.2.3 
and 2.2.6 to identify and quantify protein expression.  
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2.4 PROTEIN DETECTION 
Membranes were subjected to extensive antibody washes after protein separation described 
in section 2.2.4-2.2.6. Table 2.3 and 2.4 outline optimised conditions for each Western blot. 
2.4.3 PROTEIN VISUALISATION AND QUANTIFICATION 
Protein detection and quantification was conducted using LI-COR’s Odyssey imaging 
machine and software (LI-COR Biosciences, Lincoln, Nebraska, USA).    
2.4.1 OPTIMISED GEL RUNNING CONDITIONS 
Table 2.3: Running conditions for different proteins of interest in rat placental samples 
  
Protein of 
Interest 
Rat 
Placenta BeWo Fraction 
Total 
Protein 
Loaded 
(µg) 
Gel % Heat Denatured Reduced 
TRPV6   Membrane 20 4-12   
Calbindin-
D9k 
  Cytoplasmic 50 12   
PMCA   Membrane 50 4-12   
SNAT 2   Membrane 20 4-12   
CLOCK   Cytoplasmic/Nuclear 50 4-12   
BMAL1   Cytoplasmic/Nuclear 20 4-12   
IGF-II   Membrane 40 12   
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2.4.2 OPTIMISED ANTIGEN CONDITIONS 
Table 2.4: Primary antigen details including supplier details and probing conditions. 
 
Antigen validations experiments were conducted by way of negative and positive controls. 
Negative controls omitted the primary antibody to look for unspecific binding and noise, 
where positive controls were conducted using the recommended cell/protein on each data 
sheet, known to contain the desired protein. Conditions for the antigen detection stayed the 
same as those outlined in the above table.
Antigen Supplier Host Blocking Buffer Antibody Buffer 
Antibody 
Dilution 
TRPV6 
Santa-Cruz 
Biotechnology 
Inc 
Rabbit 
2% Milk 
Powder, 
TBST 0.1% 
TBST 0.1% 1:1000 
Calbindin-
D9k SWANT Rabbit 
3% Milk 
Powder, 
TBST 0.05% 
3% Milk Powder, 
TBST 0.05% 1:1000 
PMCA Gene-Tex Mouse 
2% Milk 
Powder, 
PBS 
PBST 0.05% 1:1000 
SNAT 2 
Santa-Cruz 
Biotechnology 
Inc 
Mouse 
2% Milk 
Powder, 
PBST 0.1% 
1% Milk Powder, 
PBST 0.1% 1:1000 
CLOCK Ab-Cam Rabbit No Block TBST 0.1% 1:10,000 
IGF-II Millipore Mouse 
2% Milk 
Powder, 
PBST 0.005% 
PBST 0.005% 1:200 
BMAL1 Ab-Cam Mouse 
2% Milk 
Powder, 
TBST 0.1% 
TBST 0.1% 1:100 
Beta-Actin Ab-Cam Mouse N/A N/A 1:15,000 
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CHAPTER 3: DISRUPTION OF KEY TRANSPORT AND REGULATORY 
PROTEINS IN RAT PLACENTA WHEN SUBJECTED TO MATERNAL 
INTERMITTENT FASTING 
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3.1 INTERMITTENT FASTING ANIMAL STUDY 
3.1.1 DIETARY REGIMES, FOOD INTAKE AND MATERNAL WEIGHT GAIN DURING 
PREGNANCY 
During gestation maternal food intake in IF rats and control counterparts was monitored over 
24 hour periods from copulation to term (figure 3.1.1A). Daily food intake is quantified as 
grams of food consumed per 100g of bodyweight. Food consumption in IF rats was lower at 
every time point when compared to control (2 Way ANOVA, p<0.001) which reflects the diet 
regimes of constant or intermittent food availability. For both diet regimes, a significant 
increase in food intake was recorded near term when compared to earlier gestation (2 Way 
ANOVA, p<0.01). 
Maternal weight gain in IF and control pregnant rats was recorded daily from copulation to 
term (figure 3.1.1B). Maternal weight gain (g) increased gradually as gestation progress in 
both diet regimes (2 Way ANOVA, p<0.001) which reflects expected maternal weight gain 
due to fetal and placental growth. Despite weighing the same at copulation (E0) dams 
subjected to the IF diet regime gained weight at a slower rate throughout their pregnancy 
resulting in significantly lower maternal weight at term (2 Way ANOVA, p=0.02) 
 
3.1.2 EFFECT OF DIETARY REGIME ON FETAL AND PLACENTAL WEIGHTS 
At E21, fetal and placental weights were recorded from litters of mothers that underwent IF 
or control diets. Mothers that underwent the IF regime had litters with increased fetal weights 
(figure 3.1.2A) and decreased placental weights (figure 3.1.2B; Mann-Whitney U, p<0.01) 
compared to those from mothers on a control diet. Due to this, the fetal:placental weight ratio 
of pups from mothers under the IF regime was increased (figure 3.1.2C, Mann-Whitney U, 
p<0.01) compared to mothers on control diets implying an increased fetal weight generated 
per gram of placenta. 
 
61 
 
 
 
 
 
Figure 3.1.1: (A) Daily maternal food intake in IF rats (black triangles, n=9) was significantly lower when 
compared to intake in control rats (grey squares, n=11) throughout gestation (E0-E21) (Mann-Whitney U, 
p<0.0001). Food intake increased significantly in late gestation for both IF and control groups (2 Way 
ANOVA, p<0.01). (B) Daily maternal weight gain in IF rats and control rats showed significant increases 
throughout gestation (E0-E21) (2 Way ANOVA, p<0.001). Maternal weight gain in the IF diet regime was 
significantly lower when compared to control dams throughout gestation (2 Way ANOVA, p<0.05). +/- 
SEM 
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Figure 3.1.2: The IF dietary regime (n=66) resulted in A) increased fetal weight (p<0.01), B) decreased 
placental weight (p<0.01) and C) increased fetal:placental weight ratio (p<0.01) at E21 compared to 
control counterparts (n=85)  Statistical tests performed were Mann-Whitney U. +SEM. 
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3.1.3 PROTEIN CONCENTRATION OF RAT PLACENTAS 
The total protein concentration from the cytoplasmic and membrane fractions of rat 
placentas, from both IF and control diet regimes, was recorded at term (figure 3.1.3). The 
total protein concentration of the IF cytoplasmic fraction was significantly lower than the 
cytoplasmic fraction from control counterparts (Mann-Whitney U, p<0.05). For both diet 
regime groups, the protein concentration of the membrane fraction is greater than 
corresponding cytoplasmic fractions (Mann-Whitney U, p<0.05). 
 
3.1.4 PLACENTAL CONTENT OF TARGET PROTEIN: TRPV6, PMCA, SNAT2, 
PLACENTAL IGF-II AND CLOCK 
The presence of placental proteins was quantified in the placental membrane fraction of IF 
and control samples (n=6/group; figure 3.1.4). Protein is expressed as density (%) of Beta-
Actin - a house keeping protein. 
The presence of TRPV6, PMCA and SNAT2 is significantly decreased in the membrane 
fraction of IF samples when compared to samples which were subjected to the control diet 
regime (figure 3.1.4A, B, and D; Mann Whitney U, p<0.01).  Diet regime had no detectable 
differences on placental content of calbindin-D9k proteins (figure 3.1.4C).  
The presence of placental CLOCK protein is significantly increased in IF samples when 
compared to control counterparts (figure 3.1.5A; Mann Whitney U, p<0.05). Diet regime had 
no detectable differences on placental content of calbindin-D9k or IGF-II proteins (figure 
3.1.5B).  
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Figure 3.1.3: Total protein concentration of cytoplasmic and membrane fractions from IF and control 
samples (n=6/group). For both diet groups, placental protein from cytoplasmic fractions was less than in 
membrane fractions (Mann Whitney U, p<0.05) Total protein concentration of the cytoplasmic fraction 
from IF samples was significantly lower than controls (Mann-Whitney U, p<0.05), however no effect of 
diet regime was seen between membrane fractions and maternal diet. The median is represented by the 
horizontal line. 
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Figure 3.1.4: Western blots quantified protein content of membrane fractions of placentas from litters of 
rats fed on control or IF dietary regimes. Representative Western blots are presented and all data were 
normalized against the house keeping protein β-Actin. IF reduces presence of placental TRPV6 (A), 
PMCA (B) and SNAT2 (D) in the rat when compared to control diet counterparts (Mann Whitney U, 
p<0.01; n=6). Maternal diet had no apparent effect on content of Calbindin-D9k in the cytoplasmic fraction 
(C; n=6). The median is represented by the horizontal line. 
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Figure 3.1.4: Western blots quantified protein content of membrane fractions of placentas from litters of 
rats fed on control or IF dietary regimes. Representative Western blots are presented and all data were 
normalised against the house keeping protein β-Actin. Placental content of CLOCK protein (A) was 
increased in placentas of IF fed rats compared to control diet (Mann-Whitney U, p<0.05; n=5). Maternal 
diet had no apparent effect on content of IGF-II (B; n=6). The median is represented by the horizontal 
line. 
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CHAPTER 4:  THE IDENTIFICATION AND MANIPULATION OF 
CORE CIRCADIAN PROTEINS IN THE TROPHOBLASTIC CELL 
LINE: BEWO. 
  
(A) 
(B) 
) 
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4.1 BEWO VIABILITY ASSAY 
 
Nuclei isolated from BeWo were visualised under a light microscope of after staining with 
trypan blue (figure 4.1). Dark spots indicate isolated nuclei whereas cytoplasmic debris is 
identified as smears. No cytoplasmic debris was seen in the nuclei isolations indicating a 
high level of nuclei purity. 
 
4.2 QUANTIFICATION OF CLOCK AND BMAL1 IN NUCLEAR AND CYTOPLASMIC 
FRACTIONS OF BEWO 
Nucleic and cytoplasmic BeWo fraction Western blot analysis to confirm the presence and 
localisations of key circadian regulators CLOCK and BMAL1 in the choriocarcinoma cell line 
BeWo is shown in figure 4.2.1. Both fractions displayed clear signals, however BMAL-1 does 
appear to be made up of several close bands, indicating the presence of CLOCK and 
BMAL1 in both the nuclei and cytoplasm of the choriocarcinoma cell line. Sample fractions 
were loaded alternately to allow for easy comparison and identification of immune signals. 
Total protein content of the nuclei and whole cell lysate fractions isolated from BeWo cells 
cultured at 10, 20, 30 and 45mmol/l (n=3). Protein content was quantified as µg/µl. 
Figure 4.2.2 shows the change of glucose concentration in the growth medium does not 
affect the total protein concentration in either nuclear of whole cell fractions. 
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A 
D 
B 
C 
  
Figure 4.1: Visualisation of trypan blue nuclei quality assays (2.3.11) under a light microscope. BeWo 
were cultured in 10 (A), 20 (B), 30 (C), and 45 (D) mmol/l glucose concentration. Dark spots are 
representative of isolated nuclei whereas cytoplasmic debris are characteristic by smears, of which there 
are none. 
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(A)  BMAL1 
(B)  CLOCK 
Figure 4.2.1: Representative Western blots of the key circadian regulators (A) BMAL1 68kDa and (B) 
CLOCK 95kDa in both the nucleic and cytoplasmic fractions of the choriocarcinoma cell line BeWo. 
Clear signals indicate that the circadian machinery is localised in both fractions. 
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Figure 4.2.2: Protein concentration of both nucleic (A) and cytoplasmic (B) fractions isolated from 
BeWo cultured at varying glucose concentrations; 10, 20, 30 and 45mmol/l. Protein is displayed as 
µg/µl (n=3). The median is represented by the horizontal line. 
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The presence of circadian machinery proteins was quantified and compared in nuclear and 
cytoplasmic fractions were cultured in 10, 20, 30 and 45 mmol/l glucose concentrations in 
BeWo (n=3; figure 4.2.3). Western blot analysis of circadian machinery was normalised 
against the house keeping protein Beta-Actin and displayed as a density (%). Densitometric 
analysis shows changed protein content of trophoblastic CLOCK and BMAL1 with increasing 
concentrations of glucose in the media. CLOCK significantly decreases between 10 and both 
30 and 45mmol/l glucose concentrations in nucleic fractions (A), and between 10 and 
45mmol/l in cytoplasmic fractions (Kruskal-Wallis with Dunn’s multiple comparisons, 
p<0.0001). Nuclear (C) and Cytoplasmic (D) content of BMAL1 protein is significantly 
increased at 10mmol/l compared to all other glucose concentrations (One-way ANOVA 
Tukeys post hoc, p<0.01). No differences were observed between 20-45 mmol/l media 
glucose concentrations. Β-Actin expression remained unchanged throughout glucose 
concentration changes. 
CLOCK and BMAL1, quantified in nucleic and cytoplasmic fractions of BeWo cultured in 10 
(A), 20 (B), 30 (C) and 45 (D) mmol/l glucose media concentrations was shown in figure 
4.2.4.  Densitometric analysis shows no significant difference between cytoplasmic and 
nucleic content of CLOCK or BMAL at each glucose concentration (Mann Whitney U).  
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Figure 4.2.3: The content of circadian machinery proteins, CLOCK and BMAL1, were quantified in the 
nucleic and cytoplasmic fraction of BeWo cells cultured in 10, 20, 30 and 45mmol/l glucose (n=3). All 
data were normalised against the house keeping protein β-Actin. CLOCK significantly decreases 
between 10 and both 30 and 45mmol/l glucose concentrations in nucleic fractions (A), and between 10 
and 45mmol/l in cytoplasmic fractions (Kruskal-Wallis with Dunn’s multiple comparisons, p<0.0001). 
BMAL1 is significantly higher in 10mmol/l compared to 20 mmol/l glucose concentrations in both the 
nucleic (C) and cytoplasmic (D) fractions (Kruskal-Wallis with Dunn’s multiple comparisons, p<0.001 and 
0.05 respectively). +/- SEM. 
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Figure 4.2.4: The expression of CLOCK and BMAL1 in nuclear (N) and cytoplasmic (Cyto) fractions of 
BeWo in (A) 10, (B) 20, (C) 30 and (D) 45mmol/l glucose concentration in the culture medium. There 
were no differences between nuclear and cytoplasmic CLOCK or BMAL1 expression in any glucose 
concentration. +/- SEM. 
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4.3 STIMULATION OF CYCLIC CLOCK AND BMAL1 FEEDBACK LOOPS IN BEWO 
4.3.1 CELL VIABILITY FOLLOWING SERUM SHOCKING 
Cell viability MTT assays were performed on BeWo before (0, n=12), directly after the 2 hour 
serum shock (2, n=31) and 48 hours (48, n=36) after the addition of serum free media (figure 
4.3.1). MTT metabolism during the cell serum shocking procedure resulted in no significant 
difference in the reduction of MTT to the insoluble form when compared to pre serum 
shocked counterparts.  
4.3.2 MEASURING OF CYCLIC ACTIVITY OF CLOCK AND BMAL1 
The expression of the key circadian regulators CLOCK and BMAL1 were monitored in BeWo 
every 6 hours for a period of 48 hours after the serum shock procedure and in control 
samples using Western blotting (figure 4.3.2). Results are displayed as a density (% of β-
Actin). Expression of CLOCK and BMAL1 in control tissue (A) recorded significantly higher 
levels of CLOCK compared to BMAL1 counter parts. After the serum shock procedure (B) 
the expression of CLOCK is significantly reduced compared to control samples (one way 
ANOVA, p<0.05) and the expression levels recorded closely match BMAL1 expression in 
serum shocked samples. 
4.3.3 LEVELS OF CALCIUM TRANSPORT PROTEINS, TRPV6 AND PMCA, IN 
SERUM SHOCKED BEWO 
The expression of the key calcium transporters TRPV6 and PMCA was monitored in BeWo 
every 6 hours for a period of 48 hours after the serum shock procedure and in control 
samples using Western blotting (figure 4.3.3). Results are displayed as a density (% of β-
Actin). Expression of TRPV6 in control and serum shocked samples (A) displayed no 
significant difference at any time point. The expression of PMCA in serum shocked samples 
and control counterparts (B) similarly showed no variation after the serum shock procedure. 
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Figure 4.3.1: Cell viability as measured by the MTT assay shows no difference between the reduction of 
MTT at time 0 (n=12) or 48 (n= 36) hours post serum shock procedure. +/- SEM. 
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Figure 4.3.2: The expression of CLOCK and BMAL1 in BeWo measured via Western blotting in control 
samples (A) and after the serum shock procedure (B) (n=3/time point). Expression was recorded every 6 
hours for a period of 48 hours post serum shock. CLOCK expression was significantly reduced after 
serum shocking when compared to control counterparts (One way ANOVA, p<0.05). +/- SEM. 
A) 
B) 
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  Figure 4.3.3: The expression of TRPV6 (A) and PMCA (B) in BeWo measured via Western blotting in 
control samples and after the serum shock procedure (n=3/ time point). Expression was recorded every 
6 hours for a period of 48 hours post serum shock. TRPV6 and PMCA expression is unaltered after the 
serum shock procedure. +/- SEM. 
A) 
B) 
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4.3.4 LEVELS OF SYSTEM A TRANSPORT PROTEIN, SNAT2, IN SERUM 
SHOCKED BEWO 
The expression of SNAT2 was monitored in BeWo every 6 hours for a period of 48 hours 
after the serum shock procedure and in control samples (n=3/time point; figure 4.3.4). 
Results are displayed as a density (% of β-Actin). The levels of SNAT2 protein in control 
displayed no significant difference post serum shocking. 
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Figure 4.3.4: The expression of SNAT2 in BeWo measured via Western blotting in control samples and 
after the serum shock procedure (n=3/time point). Expression was recorded every 6 hours for a period of 
48 hours post serum shock. SNAT2 expression displays no significant difference after the serum shock 
procedure (n=3/time point). +/- SEM. 
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CHAPTER 5: DISCUSSION 
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The rat model of IF presented in this study shares characteristics seen in human pregnancy 
during Ramadan with regards to pregnancy outcome. The rat placenta was reduced in size 
following maternal IF in common with observations in humans during a period of Ramadan 
type fasting (Alwasel et al. 2010). The IF during the gestational period in the rat also brought 
about significant changes in the protein expression of key calcium and amino acid 
transporters in the placenta. This period of IF also altered the protein expression of the key 
circadian regulatory protein CLOCK in the rat placenta. It is not clear whether this was due to 
the abnormal dietary cues or the disrupted sleeping pattern which came about as a result of 
IF in the rat. The circadian machinery was shown to be expressed in the human 
choriocarcinoma cell line BeWo which is a model of the syncytiotrophoblast. However, a 
serum shock procedure was unable to stimulate circadian oscillations in the circadian 
regulators CLOCK and BMAL1 as it has previously been reported to do in another placental 
model clock genes (Frigato et al. 2009). However it did act to bring the protein expression 
levels of CLOCK and BMAL1 into close association. The altered expression of CLOCK 
combined with the serum shock procedure did not affect the expression of key nutrient 
transporting proteins for calcium and amino acids in BeWo.   
The in vivo IF model investigated in this report was able to mimic certain outcomes reported 
in human pregnancy. The decrease in placental size in the rat during IF mirrors a similar 
decrease seen in Saudi Arabia during human gestation (Alwasel et al. 2010). It was reported 
that placental size was decreased in the second or third trimester of human pregnancies 
(p<0.002 for both boys and girls) when subjected to Ramadan fasting compared to non-
fasting counterparts. Despite the reduction in size, the placenta was able to maintain normal 
fetal development and to this end birth weight was unaffected (Alwasel et al. 2010). The IF 
rat model produced an increased fetal birth weight as well as decreased placental size at 
term. Previous papers have alluded to a placental reserve capacity that is able to increase 
the efficiency of the placenta per gram of placental tissue when environmental stressors 
occur during pregnancy (Baergen 2007;Coan et al. 2008;Fox 1997). This reserve capacity 
has previously been investigated with regards to placental morphology. The authors found 
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that volume of labyrinthine zone in mouse placenta was increased at E16 in the smallest 
placenta from each sampled litter coupled with up-regulated expression of the SNAT2 gene 
E19 (Coan et al. 2008). It may be that the IF period during gestation causes a big enough 
insult to fetal development that the placenta calls upon the reserve capacity to maintain fetal 
growth at a normal trajectory in the rat model. The increased fetal weight recorded in the IF 
rat model could be a result of the larger fasting period during the whole gestational period. If 
fasting were to happen in human gestation for the same period it may well be that similar 
results occur.    
Following gestational IF, the expression of key calcium transporting proteins and SNAT2 in 
the rat placenta was significantly lower than controls. The decrease in the protein expression 
of TRPV6, PMCA and SNAT2 is counter to the afore reported labyrinthine zone volume 
expansion in smaller placentas (although no morphological studies were conducted for this 
particular IF study) and the SNAT2 amino acid transporting gene up regulation in the mouse 
(Coan et al. 2008). The decrease in TRPV6 protein expression at term in the rat placenta 
following IF could affect calcium flux from maternal to fetal compartments. Work conducted 
using the TRPV6 knockout mouse recorded a significant decrease in calcium transport 
across the placenta (Suzuki et al. 2008). It is possible that the IF rat model could be 
associated with a decrease in calcium transport from the maternal circulation due to the 
decrease in TRPV6 protein expression. It has also previously been reported that, in the rat, 
the activity of PMCA does not mirror its expression (Nabekura et al. 2004). It may be that 
this is the case with the down regulated nutrient transporter protein expression observed in 
the current study and, an increase in activity may make up for the decrease in protein 
expression. In a previous study looking at pre-eclampsia and the affect it had on placental 
nutrient transporters in human gestation the authors reported an increase in TRPV6 and 
PMCA expression on both the maternal and fetal side of the placenta (Yang et al. 2013). 
This is at odds with the changes seen in our IF study, however it should be taken into 
consideration the difference between a controlled period of fasting and a pre-eclampsia 
pathology. Interestingly, the protein levels of Calbindin-D9K remain unchanged in the rat 
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placenta at term after a period of IF. In the past it has been suggested that Calbindin-D9K is 
rate limiting for calcium transport across the placenta in rodents (Dilworth et al. 2010;Bond et 
al. 2008;Glazier et al. 1992). It could be that the effect of reduced protein levels of TRPV6 
and PMCA is minimal due to sufficient calcium shuttling through the trophoblastic layers via 
unaltered levels of Calbindin-D9k in the rat model.      
The amino acid transporting protein SNAT2 was identified before the study as a good 
indicator of dietary alteration to nutrient transporters due to its well documented ability to be 
extremely adaptable under nutritional challenge (Dall'Asta et al. 1994a;Franchi-Gazzola et 
al. 1999;Franchi-Gazzola et al. 1994;Jones et al. 2006a;Novak et al. 2006). Indeed a period 
of IF significantly reduced the expression of the SNAT2 protein in the rat placenta. This 
indicates that IF during gestation caused a large enough nutritional challenge for the 
placenta to respond. The reduction in SNAT2 protein expression in the placenta is counter 
logical to the increase in fetal body weight recorded at term. Similar to calcium transporters, 
it could be that the activity of the SNAT2 transporter protein could be increased to cope with 
the decrease in protein expression. Taken together, the decreased protein expression of 
placental TRPV6, PMCA and SNAT2 indicate a change in nutrient transport activity that 
eventually leads to the increased fetal body weight at term in our rat IF model. 
 The increase in placental CLOCK after a period of IF in the rat suggested that the alteration 
to normal animal housing conditions over the gestational period (feeding during light hours) 
changed the circadian function in the placenta. It also acted to challenge the idea that the 
placenta has a more robust mechanism to contend with the cyclical nature of peripheral 
tissues (Waddell et al. 2012). The change in maternal feeding patterns is clear in the IF rat 
model utilised in this study and it could be that the placenta is just as susceptible to these 
dietary cues as other peripheral tissues. It could be postulated that it is the circadian 
disturbance rather than the nutritional mismatch that causes the effects on pregnancy 
outcome. Recent studies have shown that a simple light manipulation of maternal housing 
conditions can reduce fetal growth in the rat by up to 24% (Gozeri et al. 2008). The nature of 
the IF fasting period used in this study affects the nocturnal nature of the rat as they were 
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denied food from 5pm until 9am. The IF rat reported in this model had to contend with 
altered dietary cues as well as altered light exposure due to the disruption in their waking 
hours. 
 It must be taken into consideration that the IF rat model used here has a number of 
limitations. Firstly the whole gestational period; is subjected to the fasts whereas the 
Ramadan period would last no longer than 1 month of the human gestation. Secondly, water 
was freely available to rats during the IF period, during Ramadan water intake is also 
restricted in waking hours. Thirdly, protein expression may be slightly misleading when taken 
alone and future work should look at transporter protein activity. Lastly, although the IF 
model started to address the possibility that circadian cues play an important role during 
placental regulation in pregnancy it must be noted that the expression of CLOCK protein 
alone gives very little information on the physiology of circadian regulation. Therefore the 
relationship between the circadian clock in the placenta and nutrient transfer between 
mother and fetus remains unknown.   
Localisation of circadian machinery to the syncytiotrophoblast in both the nuclear and 
cytoplasmic fractions of the choriocarcinoma cell line BeWo and the subsequent stimulation 
of CLOCK and BMAL1 expression in BeWo using asynchronous dietary changes of glucose 
concentration led to altered protein expression in both the nucleic and cytoplasmic fractions. 
Glucose and its ability to disrupt CLOCK and BMAL is well documented, however the 
complex nature of glucose homeostasis and insulin action means the mechanisms remain 
unknown (Marcheva et al. 2010). The ability of an asynchronous dietary cue to alter the 
expression of key circadian proteins in the trophoblast alludes to a possibility that any altered 
glucose homeostasis during pregnancy may affect circadian control in the placenta. Very few 
studies have been conducted to look at placental phenotype with regards to targeted 
disruption of the clock genes. One such model, the BMAL1 knockout mouse, was found to 
be smaller and up to 30% lighter at birth than control pups (Boden et al. 2010;Kondratov et 
al. 2003). The mechanisms behind BMAL1 knockout mouse growth restriction remain 
unknown; it could be that the deletion of BMAL1 perturbs the cyclic nature of the clock which 
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has been shown to govern nutrient homeostasis in other tissues (Marcheva et al. 
2010;Wharfe et al. 2011).   
In order to elucidate the relationship between cyclical circadian oscillations and nutrient 
transport the serum shock procedure was used. Serum shocking is widely used in cell 
culture applications to investigate circadian expression of various genes (Balsalobre et al. 
1998;Matsunaga et al. 2014). In the circadian clock BMAL and CLOCK interact together to 
form a heterodimer in the cytoplasm and shuttle back into the nucleus to inhibit their own 
action in the TTO model. The serum shock procedure did not result in an oscillation of 
CLOCK and BMAL1 protein expression in the BeWo cell line. However the 48 hour period 
post serum shock showed a significant decrease in BeWo CLOCK expression. As the 
circadian elements undergo post transcriptional changes and interactions in the cell 
cytoplasm (Waddell et al. 2012), it could be that these modifications are fundamentally 
different in the placenta. This conclusion is supported by evidence that the BMAL1 and 
CLOCK cyclical phase shows no difference to other core clock genes Per1 and Per2 in the 
rat placenta which is known to be the anti-phase of the BMAL-CLOCK loop (Wharfe et al. 
2011). Both core clock loops were shown to have parallel peaks during the dark phase which 
indicates an altered circadian mechanism in rodent placenta. The decrease in the CLOCK 
expression in the serum shocked BeWo samples did act to bring the CLOCK expression 
levels into close association with BMAL1 levels. Considering the close relationship between 
CLOCK and BMAL1 in the TTO feedback loop the similar expression levels come as no 
surprise. BMAL1 expression showed no significant difference after the serum shock 
procedure and this may be more telling as it is considered to be the more influential half of 
the CLOCK-BMAL1 complex due to the E-Box element. This decrease in CLOCK expression 
which happened as a result of the serum shock did not bring about significant changes in 
nutrient transporters, it has long been suggested that the placenta has a more robust 
mechanism to cope with circadian oscillations due to the nature of the organ and this maybe 
evidence to support that theory.  
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The IF rat model was able to mimic observations in women partaking in Ramadan with 
regards to placental size. The mechanisms behind placental function were investigated and 
it was shown that IF during gestation reduced the expression of key calcium transporting 
proteins and the amino acid transporting protein SNAT2. The period of fasting also brought 
about with increased expression of the key circadian regulatory protein CLOCK. Further 
investigation into circadian control of placental nutrient transport provided insight into the 
localisation of circadian machinery to the key nutrient transporting cells of the human 
placenta. The serum shock procedure was unable to stimulate circadian oscillations in the 
placental cell line BeWo; however it did act to reduce the expression of CLOCK. This 
reduction in CLOCK did not act to alter the expression of TRPV6, PMCA or SNAT2 in BeWo 
but it could be that the isolated cell line lacks the necessary components for total control of 
the circadian clock. Further work needs to be conducted to elucidate to what extend 
disruptions to the circadian clock can control nutrient transport and homeostasis, possibly 
with further use of the rat model. The ability of the asynchronous dietary cues to influence 
circadian protein expression indicates a complex relationship between circadian control and 
nutrient homeostasis. Although this report was unable to identify a direct link between the 
two, further investigations may look at a complete organism rather than isolated cell line and 
to what extend the circadian clock influences and controls the function of key nutrient 
transporting tissues.   Data reported above is an important first step as it provides 
information into the fundamental changes that happen in key nutrient transporting proteins 
during a period of fasting in the placenta. It also tentatively begins to explore a link between 
circadian control and nutrient transport. 
6.2 FUTURE WORK 
The decrease seen in the protein expression of TRPV6, PMCA and SNAT2 suggests the 
activity must be increased to compensate and maintain fetal growth. From current data this 
can only be speculated, therefore experiments to measure transporter activity must be 
conducted. The maternal and placental clearance of radio labelled transporter substrates 
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such as Ca2+ and amino acids could be used to assess transporter protein activity during IF. 
This would provide further information on the placentas ability to cope with nutritional insult 
in utero (Constância et al. 2005).  
Isolation of specific placental zones from the rat model could provide more information with 
regards to circadian protein expression and the relationship with nutrient transporter protein 
expression throughout pregnancy. This study looked at whole expression of placental 
circadian machinery in the rat. Zone specific changes may offer further insight into circadian 
and nutrient homeostasis.  
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